Skip to main
ALHC
ALHC logo

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc. is well-positioned to capitalize on a favorable 2026 rate update, particularly as competitors reduce benefits, leveraging a significant Stars funding advantage. The company's integrated Medicare Advantage and value-based care model is expected to yield long-term market share gains and above-average growth, fostering a robust operational framework. Additionally, expected gross profit per member per month (PMPM) is projected to increase significantly, starting from $90-$150 for the first two years and progressing beyond $230 in years three to five, which underscores the potential for enhanced financial performance.

Bears say

Alignment Healthcare has demonstrated the ability to lower Average Daily Census (ADK) during a period of increased healthcare utilization, primarily influenced by post-COVID dynamics and regulatory changes. Despite operating against a publicly disclosed ADK target that signals strength in its technology and operating model, the company's valuation multiple exceeds the long-term range for peer managed care organizations, positioning it at a higher risk of valuation pressure. Furthermore, challenges related to data friction among different payors and inconsistent performance among employed or affiliated primary care providers may hinder the effectiveness of its value-based care approach, contributing to a cautious outlook on the stock.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.